Cornercap Investment Counsel’s BioAtla BCAB Stock Holding History

Cornercap Investment Counsel’s Portfolio BCAB Stock Details BCAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-596	Closed	-$52.5K	–	475
2024 Q3	$52.5K	Sell	596 -616	-51%	-$51.7K	0.02%	508
2024 Q2	$83K	Sell	1,212 -12	-1%	-$1.43K	0.01%	574
2024 Q1	$211K	Hold	1,224	–	–	0.03%	558
2023 Q4	$151K	Hold	1,224	–	–	0.02%	550
2023 Q3	$104K	Sell	1,224 -7	-0.6%	-$892	0.02%	535
2023 Q2	$185K	Hold	1,231	–	–	0.03%	522
2023 Q1	$165K	Buy	1,231 +580	+89%	+$104K	0.03%	519
2022 Q4	$269K	Hold	651	–	–	0.05%	478
2022 Q3	$251K	Sell	651 -297	-31%	-$97.2K	0.05%	463
2022 Q2	$135K	Buy	+948	New	+$151K	0.02%	516

Other funds holding BCAB

AFM

Anson Funds Management Dallas, Texas $2.29B AUM 370.24% 1-Year Est. Return

ACA

Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return

HCM

Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BCM

Boxer Capital Management San Diego, California $762M AUM 1,125.36% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Cornercap Investment Counsel's BCAB Position: Q4 2024 in Review

Cornercap Investment Counsel sold out of BioAtla (BCAB) in Q4 2024, closing a stake of 596 shares — an estimated $52.5K sold.

Cornercap Investment Counsel first reported a position in BCAB in Q2 2022 and held it in 10 quarters. The position peaked at $269K in Q4 2022. 67 funds tracked by Wall St. Rank hold BCAB as of Q4 2024.

Cornercap Investment Counsel reported no remaining BioAtla position as of Q4 2024 after selling out during the quarter.
Cornercap Investment Counsel sold 596 BioAtla shares in Q4 2024, an estimated $52.5K.
Cornercap Investment Counsel first reported a position in BioAtla in Q2 2022 and held it in 10 quarters.
Cornercap Investment Counsel's BioAtla position peaked at $269K in Q4 2022.
67 funds tracked by Wall St. Rank held BioAtla as of Q4 2024.

Based on Cornercap Investment Counsel's 13F filing for Q4 2024, filed 12 Feb 2025.